Charles Greg Guyer - May 3, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 3, 2024
Transactions value $
-$349,215
Form type
4
Date filed
5/7/2024, 05:58 PM
Previous filing
Mar 19, 2024
Next filing
Nov 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16.8K +245 +0.31% $68.65 78.6K Apr 30, 2024 Direct F1
transaction BMRN Common Stock Tax liability -$366K -4.44K -5.65% $82.44 74.1K May 3, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.